Alterations of LKB1 and KRAS and risk of brain metastasis: Comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma

LKB1 CN in combination with KRAS mutation predicted brain metastasis in NSCLC.